MaaT Pharma reports positive Phase III results for MaaT013, its microbiome-based therapy for gastrointestinal GvHD, achieving ...

AiCuris appoints Jacques Dumas as CSO to lead research efforts as the company refocuses on infectious disease therapies for ...

Angelini Ventures co-leads a $21 million series A round for Neumirna Therapeutics, supporting its RNA-based therapies for ...

Insilico Medicine raises over $100 million in series E funding to advance AI-driven drug discovery, including ISM001-055, the ...

Calico Life Sciences, a biotech founded by Alphabet and Arthur Levinson focused on the biology of aging and age-related ...

Canadian biotech Aspect Biosystems, which is developing bioprinted tissue therapeutics as a new category in regenerative ...

Privately-held US biotech Alloy Therapeutics has announced a target specific collaboration and license agreement for the use ...

Antag Therapeutics, a Denmark-based biopharma developing novel treatments for obesity, has announced the appointment of Joerg ...

Vertex Pharmaceuticals and Orna Therapeutics announce a $4 billion collaboration to develop in vivo gene editing therapies ...

Denmark’s Novo Nordisk and Valo Health today announced they have entered into an expanded agreement to discover and develop ...

Californian oncology-focused biotech Avenzo Therapeutics and China-based Duality Biotherapeutics (DualityBio) have entered ...

Galapagos plans to split into two entities by mid-2025, focusing its core business on cell therapies while spinning off a new ...